Source: StreetInsider

Press Release: Entasis Therapeutics : Entasis Therapeutics Appoints Dr. David Altarac as Chief Medical Officer

Dr. Robin Isaacs to Retire at the End of the Year WALTHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Manos Perros's photo - President & CEO of Entasis Therapeutics Holdings, Inc.

President & CEO

Manos Perros

CEO Approval Rating


Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more